Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

KLRS

Kalaris Therapeutics, Inc.

CIK 0001754068 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$4.49
↓ 0.22 (-4.67%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$106.83M
P/E Ratio
-2.42
EPS
-2.85
Dividend Yield
Not covered
52W Position
24%
Beta
0.59

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.56
P/S
Not covered
EV/Revenue
Not covered
ROE
-64.3%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 24%
$2.14$11.88

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$43.44M
Total Assets
$121.74M
Free Cash Flow
-$38.57M

Recent news